Quadratus Lumborum Block Versus Control for Total Hip Arthroplasty
Launched by UNIVERSITY OF ALABAMA AT BIRMINGHAM · Jan 22, 2018
Trial Information
Current as of May 02, 2025
Completed
Keywords
ClinConnect Summary
Currently, regional anesthesia techniques for total hip arthroplasty are limited. Fascia iliac blocks have been employed to provide analgesia for hip surgeries with blockade of the femoral, lateral femoral cutaneous, and obturator nerves via injection of local anesthetic in the iliacus fascia. In addition, lumbar plexus blocks have also been employed for post-operative analgesia, but the complexity of the block is high, and complications including epidural anesthesia are not infrequent. The quadratus lumborum block is an abdominal truncal block in which local anesthetic is deposited into th...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients undergoing total hip arthroplasty
- • 2. Adults 18 years of age and older
- • 3. Patients with an American Society of Anesthesiology (ASA) physical status classification of I, II or III
- Exclusion Criteria:
- • 1. Patients with ASA physical status classification other than I, II, or III
- • 2. Patients with allergies/intolerances to local anesthetic
- • 3. Patients with pre-existing neurologic or anatomic deficits in the lower extremity on the side of the surgical site
- • 4. Patients with coexisting coagulopathy
- • 5. Patients that are pharmacologically anticoagulated will be excluded if placement of peripheral nerve block would be contraindicated according to ASRA (American Society for Regional Anesthesia) guidelines or if spinal anesthesia would be contraindicated according to guidelines
About University Of Alabama At Birmingham
The University of Alabama at Birmingham (UAB) is a prominent academic institution and research hub dedicated to advancing healthcare through innovative clinical trials. Renowned for its commitment to medical discovery and education, UAB conducts cutting-edge research across a wide array of disciplines, including oncology, cardiology, neurology, and public health. With a robust infrastructure for clinical research, UAB fosters collaboration among interdisciplinary teams, leveraging state-of-the-art facilities and resources to enhance the translation of scientific findings into effective treatments and interventions. As a leader in clinical research, UAB aims to improve patient outcomes and contribute to the broader medical community through rigorous trial design and implementation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Birmingham, Alabama, United States
Birmingham, Alabama, United States
Patients applied
Trial Officials
Promil Kukreja, MD, PhD
Principal Investigator
UAB Department of Anesthesiology, Critical Care Division
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials